Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Shin

Showing results (121-130 of 139) with videos related to

Pageof 14
Sort By:
Journal of the National Cancer Institute|October 28, 1998
Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapyL Mao, A K El-Naggar, V Papadimitrakopoulou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinomaD M Shin, B S Glisson, F R Khuri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Cisplatin, etoposide, and paclitaxel in the treatment of patients with extensive small-cell lung carcinomaB S Glisson, J M Kurie, R Perez-Soler, et al.
British Journal of Cancer|January 17, 2013
A phase 1 Bayesian dose selection study of bortezomib and sunitinib in patients with refractory solid tumor malignanciesR D Harvey, T K Owonikoko, C M Lewis, et al.
Oncogene|October 20, 2009
Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cellsG-Y Jang, J-H Jeon, S-Y Cho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trialD M Shin, F R Khuri, B Murphy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: toxicities and responsesA S Garden, B S Glisson, K K Ang, et al.
Annals of Internal Medicine|July 21, 1998
A multidisciplinary approach to therapy for unresectable malignant thymomaD M Shin, G L Walsh, R Komaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancerD M Shin, N J Donato, R Perez-Soler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Predicting cancer development in oral leukoplakia: ten years of translational researchJ J Lee, W K Hong, W N Hittelman, et al.
Pageof 14

Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
Journal of the National Cancer Institute|October 28, 1998
Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapyL Mao, A K El-Naggar, V Papadimitrakopoulou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinomaD M Shin, B S Glisson, F R Khuri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Cisplatin, etoposide, and paclitaxel in the treatment of patients with extensive small-cell lung carcinomaB S Glisson, J M Kurie, R Perez-Soler, et al.
British Journal of Cancer|January 17, 2013
A phase 1 Bayesian dose selection study of bortezomib and sunitinib in patients with refractory solid tumor malignanciesR D Harvey, T K Owonikoko, C M Lewis, et al.
Oncogene|October 20, 2009
Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cellsG-Y Jang, J-H Jeon, S-Y Cho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trialD M Shin, F R Khuri, B Murphy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: toxicities and responsesA S Garden, B S Glisson, K K Ang, et al.
Annals of Internal Medicine|July 21, 1998
A multidisciplinary approach to therapy for unresectable malignant thymomaD M Shin, G L Walsh, R Komaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancerD M Shin, N J Donato, R Perez-Soler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Predicting cancer development in oral leukoplakia: ten years of translational researchJ J Lee, W K Hong, W N Hittelman, et al.
Pageof 14